Besides, circulating exosomal miR‐3126‐5p in plasma was also increased in NSCLC patients, with a positive correlation with GLUT1/LDHA level and low survival in NSCLC patients, which provided a clinical interrelation with glucose metabolic reprogramming. The gene discussed is SLC2A1; the disease is non-small cell lung carcinoma.